The recipient underwent a six-hour operation in November, surviving on the artificial heart for over 100 days until a donor ...

In 1984 the first successful electric pulsatile Novacor LVAD was implanted as a bridge to transplantation. The pulsatile HeartMate XVE was granted Food and Drug Administration (FDA) approval for ...

New Delhi: In a first, an Australian man has become the first in the world to live with a durable total artificial heart ...

A celebration was held Tuesday for patients with heart failure who are now living a normal life thanks to an implanted device ...

Cadrenal Therapeutics has partnered with Abbott for the TECH-LVAD trial to assess the safety and efficacy of tecarfarin in ...

Devices are implanted through a median sternotomy; in a LVAD, the inflow cannula is connected to the apex of the left ventricle (LV) and the outflow cannula is connected to the ascending aorta ...

Left ventricular assist devices, which are mechanical heart pumps, are an important treatment for patients with advanced ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized ...

In 2018, she had a left ventricular assist device (LVAD) implanted, and at 37, she questioned how she would ever find love. The LVAD served as a temporary remedy to her heart problems. The Queens ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Collaboration Agreement with Abbott for Phase 3 TECH-LVAD Trial On March 4, 2025, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced a ...

Impella RP offers up to 14 days of use in patients who develop acute right heart failure after left ventricular assist device (LVAD) implantation. Placed in the internal jugular vein, it supports ...